Recent studies have shed new light onto this issue by showing evidence of direct binding of TREM2 to Aβ oligomers with nanomolar affinity, whereas AD-associated TREM2 mutations show reduced Aβ binding (Zhao et al., 2018; Zhong et al., 2018). This evidence concerns the gene TREM2 and Alzheimer disease.